Caris Life Sciences Inc (CAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 50,450 | 46,985 | 40,055 | 45,741 | 35,618 |
| Receivables | 54,839 | 54,801 | 55,451 | 51,872 | 51,075 |
| Income taxes - deferred | N/A | N/A | N/A | N/A | 2,189 |
| Other current assets | 18,021 | 21,789 | 21,072 | 18,551 | 12,595 |
| TOTAL | $138,022 | $137,280 | $130,719 | $130,967 | $116,912 |
| Non-Current Assets | |||||
| PPE Net | 1,566,207 | 1,522,041 | 1,472,767 | 1,466,482 | 1,438,446 |
| Investments And Advances | 79,890 | 78,889 | 79,016 | 68,210 | 63,088 |
| Intangibles | 368 | 476 | 577 | 677 | 769 |
| Other Non-Current Assets | 8,488 | 8,743 | 8,998 | 9,253 | 9,508 |
| TOTAL | $1,654,953 | $1,610,149 | $1,561,358 | $1,544,622 | $1,511,811 |
| Total Assets | $1,792,975 | $1,747,429 | $1,692,077 | $1,675,589 | $1,628,723 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 183,216 | 229,906 | 73,880 | 74,080 | 74,280 |
| Accounts payable and accrued liabilities | 65,392 | 46,083 | 43,774 | 67,998 | 25,054 |
| Accrued Expenses | 8,641 | 6,799 | 4,866 | 6,230 | 8,631 |
| TOTAL | $266,663 | $292,994 | $131,322 | $157,091 | $116,565 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,055,335 | 985,860 | 1,086,432 | 1,058,628 | 1,072,630 |
| Deferred Revenues | 8,199 | 8,777 | 6,987 | 6,862 | 6,656 |
| Other Non-Current Liabilities | -38 | -48 | 40 | 0 | 0 |
| TOTAL | $1,098,903 | $1,030,028 | $1,130,812 | $1,103,372 | $1,114,304 |
| Total Liabilities | $1,365,566 | $1,323,022 | $1,262,134 | $1,260,463 | $1,230,869 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 20,783 | 21,116 | 22,242 | 22,241 | 22,241 |
| Common Shares | 2 | 2 | 2 | 2 | 2 |
| Retained earnings | 276,735 | 260,340 | 246,894 | 232,623 | 217,032 |
| Other shareholders' equity | -3,593 | -1,681 | -1,653 | -1,762 | -2,699 |
| TOTAL | $427,409 | $424,407 | $429,943 | $415,126 | $397,854 |
| Total Liabilities And Equity | $1,792,975 | $1,747,429 | $1,692,077 | $1,675,589 | $1,628,723 |